Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2020-03-09 Fund Information / Fact…
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Pursuant to regulation 30 of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015; we hereby attached the schedule of Analyst / ....
Fund Information / Factsheet Classification · 90% confidence The document is very short (382 characters) and contains a table listing dates, fund/investor names, venues, and types of meetings, including 'Call' and 'Inperson'. There is no detailed financial data, no report content, no regulatory language, and no mention of filings or announcements. The content resembles a brief summary or factsheet of meetings or investor interactions rather than a full report or announcement. Given the brevity and nature of the content, it best fits the category of Fund Information / Factsheet (FS), which is a brief summary of key company facts or market info.
2020-03-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Share and Takeover) Regulations, 2011. It details the acquisition of shares by Life Insurance Corporation of India in Cipla Limited, including shareholding percentages before and after acquisition, mode of acquisition, and dates. This type of filing is a notification of a major shareholding change, specifically related to substantial acquisition and takeover regulations. It is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and content confirm it is a full disclosure, not just an announcement or certification.
2020-03-05 English
Allotment of ESOP/ESPS
Regulatory Filings Classification · 95% confidence The document text is extremely short (127 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report content, or any descriptive text. Given the lack of content, this cannot be classified as a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2020-03-05 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 4th ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (127 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-03-05 English
Pursuant to regulation 30 of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015,enclosed is the schedule of Analyst / Institutional ....
Investor Presentation Classification · 90% confidence The document contains a schedule of analyst and institutional investor meetings with the company, listing dates, investor names, venues, and types of meetings. There is no financial data, report content, or regulatory filing information. The document is essentially an investor relations schedule or presentation material. This fits best under Investor Presentation (IP) as it is detailed information intended for investors about meetings and engagement, rather than a formal report or announcement.
2020-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document is a short schedule listing analyst and institutional investor meetings with the company, including dates, investor names, venues, and meeting types. It does not contain financial data, report content, or regulatory announcements. It is not a report, announcement of voting results, or any formal filing. The content aligns best with an Investor Presentation (IP) or related investor communication. Given the brevity and nature of the document as a schedule of investor meetings, it fits best under Investor Presentation (IP).
2020-03-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.